Skip to Main Content

Paper Details

Vaccination Against SARS-CoV-2 in Neuroinflammatory Disease: Early Safety/Tolerability Data.
Mult Scler Relat Disord
22
2022
Author NameAffiliation
Zongqi XiaUniversity of Pittsburgh Department of Neurology Pittsburgh
Zongqi XiaUniversity of Pittsburgh Department of Neurology Pittsburgh
Erin E LongbrakeYale University School of Medicine Department of Neurology New Haven
Philip L De JagerMultiple Sclerosis Center and the Center For Translational & Computational Neuroimmunology, Columbia University Irving Medical Center Department of Neurology. New York
Philip L De JagerMultiple Sclerosis Center and the Center For Translational & Computational Neuroimmunology, Columbia University Irving Medical Center Department of Neurology. New York
  • 1 - 5

Datasets